{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:36:00Z","timestamp":1791639360054,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.cmi.2020.08.025","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T04:57:48Z","timestamp":1598590668000},"page":"910.e1-910.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Dalbavancin exposure in\u00a0vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"27","author":[{"given":"Brian J.","family":"Werth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel K.","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsi","family":"Penewit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Waalkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan H.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Salipante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.08.025_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.025_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-3164.2009.00856.x","article-title":"New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach","volume":"20","author":"Blondeau","year":"2009","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cmi.2020.08.025_bib3","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1128\/AAC.00098-14","article-title":"Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E.\u00a0faecalis","volume":"58","author":"Werth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib4","series-title":"Dalbavancin for injection","year":"2014"},{"key":"10.1016\/j.cmi.2020.08.025_bib5","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.cmi.2017.07.028","article-title":"Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen","volume":"24","author":"Werth","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.08.025_bib6","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/jac\/dkz562","article-title":"Occurrence of cross-resistance and \u03b2-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels","volume":"75","author":"Hines","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib7","series-title":"M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard tenth edition","year":"2015"},{"key":"10.1016\/j.cmi.2020.08.025_bib8","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/AAC.00687-16","article-title":"Fosfomycin enhances the activity of daptomycin against vancomycin-resistant Enterococcus in an in\u00a0vitro pharmacokinetic\/pharmacodynamic model","volume":"60","author":"Hall Snyder","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AAC.01586-12","article-title":"Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.48.3.940-945.2004","article-title":"Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers","volume":"48","author":"Leighton","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/0091270008321273","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic","volume":"48","author":"Dowell","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cmi.2020.08.025_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11534440-000000000-00000","article-title":"New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin","volume":"70","author":"Zhanel","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2020.08.025_bib13","series-title":"DurataTherapeutics U.S. Limited","year":"2018"},{"key":"10.1016\/j.cmi.2020.08.025_bib14","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.jchromb.2011.07.027","article-title":"Dalbavancin: quantification in human plasma and urine by a new improved high performance liquid chromatography-tandem mass spectrometry method","volume":"879","author":"Alebic-Kolbah","year":"2011","journal-title":"J\u00a0Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.cmi.2020.08.025_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005413","article-title":"A\u00a0year of infection in the intensive care unit: prospective whole genome sequencing of bacterial clinical isolates reveals cryptic transmissions and novel microbiota","volume":"11","author":"Roach","year":"2015","journal-title":"PLOS Genet"},{"key":"10.1016\/j.cmi.2020.08.025_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1101\/gr.214346.116","article-title":"ABySS 2.0: resource-efficient assembly of large genomes using a Bloom filter","volume":"27","author":"Jackman","year":"2017","journal-title":"Genome Res"},{"key":"10.1016\/j.cmi.2020.08.025_bib17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cmi.2020.08.025_bib18","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cmi.2020.08.025_bib19","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","article-title":"Variant review with the integrative genomics viewer","volume":"77","author":"Robinson","year":"2017","journal-title":"Canc Res"},{"key":"10.1016\/j.cmi.2020.08.025_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A\u00a0program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.cmi.2020.08.025_bib21","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1128\/JB.00645-07","article-title":"New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus","volume":"189","author":"Dubrac","year":"2007","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2020.08.025_bib22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/infdis\/jis255","article-title":"Stp1 and Stk1: the Yin and Yang of vancomycin sensitivity and virulence in vancomycin-intermediate Staphylococcus aureus strains","volume":"205","author":"Cheung","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.025_bib23","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jis252","article-title":"Serine\/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus","volume":"205","author":"Cameron","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.025_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005275","article-title":"The eukaryotic-like Ser\/Thr kinase PrkC regulates the essential WalRK two-component system in Bacillus subtilis","volume":"11","author":"Libby","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cmi.2020.08.025_bib25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.08.025_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2020.08.025_bib27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jid.2016.11.045","article-title":"Human skin is the largest epithelial surface for interaction with microbes","volume":"137","author":"Gallo","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cmi.2020.08.025_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2020.08.025_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijmm.2007.02.002","article-title":"Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus","volume":"297","author":"Jansen","year":"2007","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.cmi.2020.08.025_bib30","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"Howden","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2020.08.025_bib32","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41467-019-10932-4","article-title":"Zinc-binding to the cytoplasmic PAS domain regulates the essential WalK histidine kinase of Staphylococcus aureus","volume":"10","author":"Monk","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2020.08.025_bib33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JB.186.4.1175-1181.2004","article-title":"Identification of genes controlled by the essential YycG\/YycF two-component system of Staphylococcus aureus","volume":"186","author":"Dubrac","year":"2004","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2020.08.025_bib34","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JB.187.7.2357-2367.2005","article-title":"Evidence that the essential response regulator YycF in Streptococcus pneumoniae modulates expression of fatty acid biosynthesis genes and alters membrane composition","volume":"187","author":"Mohedano","year":"2005","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2020.08.025_bib35","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3389\/fmicb.2016.01326","article-title":"The response regulator YycF inhibits expression of the fatty acid biosynthesis repressor FabT in Streptococcus pneumoniae","volume":"7","author":"Mohedano","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2020.08.025_bib36","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/jb.179.8.2557-2566.1997","article-title":"Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus","volume":"179","author":"Sieradzki","year":"1997","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2020.08.025_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drup.2013.10.002","article-title":"Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the \"seesaw effect\": taking advantage of the back door left open?","volume":"16","author":"Ortwine","year":"2013","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2020.08.025_bib38","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/AAC.00594-13","article-title":"Beta-lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus","volume":"57","author":"Berti","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.02071-15","article-title":"Penicillin binding protein 1 is important in the compensatory response of Staphylococcus aureus to daptomycin-induced membrane damage and is a potential target for beta-lactam-daptomycin synergy","volume":"60","author":"Berti","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40121-014-0023-0","article-title":"Observation of \"seesaw effect\" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains","volume":"3","author":"Barber","year":"2014","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2020.08.025_bib41","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1128\/AAC.06264-11","article-title":"The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus","volume":"56","author":"Jousselin","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01743-18","article-title":"Dalbavancin alone and in combination with ceftaroline against four different phenotypes of Staphylococcus aureus in a simulated pharmacodynamic\/pharmacokinetic model","volume":"63","author":"Kebriaei","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib43","first-page":"202","article-title":"Emergence of a dalbavancin induced glycopeptide\/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis","volume":"7","author":"Kussmann","year":"2018","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.cmi.2020.08.025_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jcpt.12580","article-title":"Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin","volume":"43","author":"Steele","year":"2018","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.cmi.2020.08.025_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1172\/JCI111965","article-title":"Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin","volume":"76","author":"Chambers","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2020.08.025_bib46","series-title":"Rocephin (ceftriaxone for injection USP) package insert","year":"2010"},{"key":"10.1016\/j.cmi.2020.08.025_bib47","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.00019-10","article-title":"Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae","volume":"54","author":"Kosowska-Shick","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/AAC.29.2.333","article-title":"Possible physiological functions of penicillin-binding proteins in Staphylococcus aureus","volume":"29","author":"Georgopapadakou","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.08.025_bib49","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/AAC.14.6.866","article-title":"Use of cefoxitin, new cephalosporin-like antibiotic, in the treatment of aerobic and anaerobic infections","volume":"14","author":"Nair","year":"1978","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20305085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20305085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:27:58Z","timestamp":1761118078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20305085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1198743X20305085"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.08.025","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dalbavancin exposure in\u00a0vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}